AU2001256809A1 - Composition for treatment of b-type hepatitis and liver cirrhosis - Google Patents

Composition for treatment of b-type hepatitis and liver cirrhosis

Info

Publication number
AU2001256809A1
AU2001256809A1 AU2001256809A AU5680901A AU2001256809A1 AU 2001256809 A1 AU2001256809 A1 AU 2001256809A1 AU 2001256809 A AU2001256809 A AU 2001256809A AU 5680901 A AU5680901 A AU 5680901A AU 2001256809 A1 AU2001256809 A1 AU 2001256809A1
Authority
AU
Australia
Prior art keywords
treatment
composition
liver cirrhosis
type hepatitis
hepatitis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001256809A
Inventor
Young Shin Chung
Eun Kyung Hong
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medvill Co Ltd
Original Assignee
Medvill Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medvill Co Ltd filed Critical Medvill Co Ltd
Publication of AU2001256809A1 publication Critical patent/AU2001256809A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/756—Phellodendron, e.g. corktree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/84—Valerianaceae (Valerian family), e.g. valerian
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU2001256809A 2000-05-02 2001-05-02 Composition for treatment of b-type hepatitis and liver cirrhosis Abandoned AU2001256809A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR0023564 2000-05-02
KR10-2000-0023564A KR100389131B1 (en) 2000-05-02 2000-05-02 Composition for B type Hepatitis and Cirrhosis of Liver Comprising Phellodendron amurense Rupr. cortex and Patrinia scabiosaefolia FISCH. Extract
PCT/KR2001/000723 WO2001082941A1 (en) 2000-05-02 2001-05-02 Composition for treatment of b-type hepatitis and liver cirrhosis

Publications (1)

Publication Number Publication Date
AU2001256809A1 true AU2001256809A1 (en) 2001-11-12

Family

ID=19667915

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001256809A Abandoned AU2001256809A1 (en) 2000-05-02 2001-05-02 Composition for treatment of b-type hepatitis and liver cirrhosis

Country Status (5)

Country Link
JP (1) JP4087114B2 (en)
KR (1) KR100389131B1 (en)
CN (1) CN100341537C (en)
AU (1) AU2001256809A1 (en)
WO (1) WO2001082941A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005239699A (en) * 2004-01-30 2005-09-08 Kobayashi Pharmaceut Co Ltd Hepatic fibrosis inhibitory agent
JP2007297289A (en) * 2006-04-27 2007-11-15 Kitasato Gakuen Antiviral agent
RU2593007C1 (en) * 2015-03-12 2016-07-27 Государственное бюджетное учреждение здравоохранения города Москвы Московский клинический научно-практический центр Департамента здравоохранения города Москвы Method of treatment hepatic cirrhosis of various etiology
KR101934673B1 (en) * 2018-05-23 2019-01-02 경희대학교 산학협력단 Compositions for Treatment and Prevention of Inflammatory Disease Comprising Extract of Patrinia scabiosaefolia as Active Ingredient

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1056424A (en) * 1990-05-11 1991-11-27 陈江辉 The syrupy compound method of Fuganning
KR100328467B1 (en) * 1994-12-21 2002-06-28 김광순 Composition for improving liver function and treating hepatitis containing extract of valerianaceae
JPH107569A (en) * 1996-06-18 1998-01-13 Kureha Chem Ind Co Ltd Hsp47 synthetic suppressant containing berberine derivative
KR100207293B1 (en) * 1996-09-16 1999-07-15 김광순 Immunostimulating composition containing mixed aqueous extract of phellodendri cortex and patrinia scabiosaefolia
KR100193216B1 (en) * 1996-12-26 1999-06-15 김광순 Treatment of acquired immunodeficiency syndrome containing mixed water extracts of Hwangbaekpi and Matari plants
KR19990015612A (en) * 1997-08-07 1999-03-05 한영복 Hepatitis C Therapeutic Composition Containing Mixed Extracts of Hwangbaekpi and Matari Plants
CN1236623A (en) * 1998-05-21 1999-12-01 姜鹏凌 Medicine for treating hepatitis B
CN1238187A (en) * 1998-08-04 1999-12-15 姜彬 Chinese herbal medicine for radically treating hepatitis B
KR100316596B1 (en) * 1999-03-30 2001-12-12 김철호 Extract of Phellodendria Cortex having activity of anticancer, antihepatitis and immunological enhancement

Also Published As

Publication number Publication date
CN1427723A (en) 2003-07-02
WO2001082941A1 (en) 2001-11-08
CN100341537C (en) 2007-10-10
KR100389131B1 (en) 2003-06-25
JP4087114B2 (en) 2008-05-21
KR20010104497A (en) 2001-11-26
JP2003531861A (en) 2003-10-28

Similar Documents

Publication Publication Date Title
EP1292603B8 (en) Methods and compositions for treating hepatitis c virus
AU2055301A (en) Alpha-ketoamide inhibitors of hepatitis c virus ns3 protease
AU2002230763A1 (en) Inhibitors of hepatitis c virus ns3 protease
AU2001245356A1 (en) Inhibitors of hepatitis c virus ns3 protease
AU2002230764A1 (en) Imidazolidinones and their related derivatives as hepatitis c virus ns3 protease inhibitors
PL332872A1 (en) Inhibitors of serinic proteases in particular that of hepatitis c virus ns3
AU6371900A (en) Lactam inhibitors of hepatitis c virus ns3 protease
AU2002330154A1 (en) Methods and compositions for treating hepatitis c virus using 4'-modified nucleosides
AU1099000A (en) Novel compounds and compositions for treating hepatitis c infections
AU2002211490A1 (en) Compositions and methods of using capsid protein from flaviviruses and pestiviruses
AU4205100A (en) Methods and compositions for the treatment of pancreatitis
PL344794A1 (en) Use of peg-ifn-alpha and ribavirin for the treatment of chronic hepatitis c
GB9825946D0 (en) Pharmaceutical compounds for the inhibition of hepatitis C virus NS3 protease
AU1324300A (en) Pentacyclic compounds useful as inhibitors of hepatitis c virus ns3 helicase
AU2001292667A1 (en) Immunogenic composition of hepatitis c and methods of use thereof
EP1141255A4 (en) Modified forms of hepatitis c virus ns3 protease
AU2001256809A1 (en) Composition for treatment of b-type hepatitis and liver cirrhosis
AU2756301A (en) Compositions comprising genome segments and methods of using the same
EP1068362A4 (en) Hepatitis c virus ns5b compositions and methods of use thereof
AU2001234596A1 (en) Use of castanospermine and substituted-castanospermine compounds for treating hepatitis virus infections
EP1173189A4 (en) Asialocytokines and treatment of liver disease
AU2001277055A1 (en) Composition for treatment of and method of monitoring hepatitis c virus using interferon-tau
GB2351904B (en) Herbal composition and use of the composition for treating viral infection of the liver
ZA200402353B (en) Methods of treating liver fibrosis and hepatitis C virus infection
AU2003256678A1 (en) Method and composition for treating and preventing hepatitis c infection